Moody's Corporation

Moody's Corporation (MCO) — Business Economics

Ticker: MCO | Currency: USD

Moody's is a toll-booth on global credit markets with a high-margin, capital-light model that is structurally strengthening.

The DNA. Moody's runs two businesses. Moody's Investors Service (MIS), the ratings franchise, charges issuers a fee every time they bring debt to market and an annual monitoring fee for maintaining the rating — essentially a recurring tax on the ~$30 trillion global bond market. Moody's Analytics (MA) sells subscription-based data, risk models, and compliance software (KYC/AML, credit decisioning, insurance analytics) to financial institutions. MIS is ~55% of revenue but ~65%+ of operating profit; MA is the faster-growing, more predictable recurring-revenue engine.

Why the engine is strengthening. Three forces compound in Moody's favor: (1) global debt stock grows secularly — more governments, corporates, and structured products need ratings; (2) MA's shift toward subscription SaaS lifts recurring revenue above 60% of total company revenue, dampening MIS's issuance-cycle volatility; (3) regulatory complexity (Basel III/IV, DORA, KYC) drives demand for MA's compliance tools. FY2025 revenue reached ~$7.1 billion (up ~11% YoY), with MIS benefiting from heavy refinancing activity and MA's ARR growing in the low-to-mid teens.

Win-win, with a caveat. Investors rely on Moody's ratings as standardized risk shorthand; issuers gain capital market access at fair pricing. The issuer-pays model carries an inherent conflict of interest — the rated entity is the paying customer — but reputational capital is the franchise's oxygen: degraded rating quality would be an existential wound. Post-2008 regulatory oversight (Dodd-Frank, ESMA) adds a structural check.

No signs of deterioration. Both segments are growing. The ratings oligopoly (Moody's, S&P, Fitch hold ~95% global share) faces no credible disruptive threat — regulatory entrenchment via NRSRO designation makes displacement nearly impossible. MA's retention rates exceed 90%.

Key governing metrics: rated issuance volume and mix (transaction vs. recurring) for MIS; ARR growth and retention rates for MA; consolidated adjusted operating margin (~47% in FY2025); and free cash flow conversion.

Market Overview — Moody's Corporation

Moody's plays in two markets that are both structurally growing: credit ratings (MIS) and risk analytics/data (MA). Both carry strong secular tailwinds over a 5–10 year horizon.

Credit ratings is a regulatory-embedded oligopoly serving global debt capital markets. The outstanding stock of global rated debt exceeds $130 trillion and grows with nominal GDP, financial deepening in emerging markets, and the secular shift from bank lending to bond financing. MIS and S&P Global Ratings collectively hold ~80% of global ratings revenue; Fitch sits at ~15%. This structure has been stable for decades — regulatory designation (NRSRO status), issuer network effects, and reputational entrenchment make displacement virtually impossible. New issuance volumes (the cyclical driver of MIS revenue) fluctuate year-to-year, but the installed base of outstanding ratings creates a recurring monitoring fee floor.

Risk analytics and data (MA) targets a broader, faster-growing TAM that Moody's management has sized at ~$30 billion and expanding. MA competes against S&P Global Market Intelligence, Bloomberg, Verisk, MSCI, and niche vendors. This market is more fragmented, but switching costs for embedded workflow tools (credit decisioning, KYC/AML, insurance analytics) provide durable retention. Regulatory complexity — Basel IV, IFRS 9, DORA, AML directives — continuously expands demand for compliance-enabling software.

Key tailwinds: private credit growth (new rating mandates), emerging-market capital market development, AI-driven analytics upsell, and expanding regulatory surface area. The only structural headwind would be a regulatory move to dismantle the issuer-pays model — politically discussed but never enacted.

Moody's has one of the deepest, most multi-layered moats in global capital markets — a rare business where nearly every moat type reinforces the others.

The core moat is a regulatory toll bridge. SEC NRSRO designation limits the ratings market to a handful of firms; Moody's and S&P together hold ~80% global share. Regulatory frameworks (Basel bank capital rules, insurance solvency standards, central bank collateral eligibility, investment mandates) hardwire NRSRO ratings into the financial system. Issuers don't choose to get rated — they must. The two-rating norm means most issuers need both Moody's and S&P, making the duopoly a double toll bridge rather than a competitive market.

Switching costs are effectively infinite on the MIS side. A bond issuer cannot retroactively change the rating on outstanding debt. Dropping Moody's would narrow investor demand and raise borrowing costs — a self-defeating act. On the MA side, decision-support tools embedded in bank credit workflows (lending origination, risk models) create high operational switching costs, with ARR reaching ~$3.3 billion by FY2025.

Data compounds irreplaceably. Over a century of default and recovery data across geographies, sectors, and credit cycles cannot be replicated. This feeds MA's risk models (EDF, RiskCalc) and AI tools, creating a flywheel: more ratings → richer data → better analytics → stickier customers.

Trajectory: widening. MA's push into GenAI-powered research assistants (Moody's Research Assistant), integrated risk platforms, and KYC/compliance solutions layers recurring software revenue atop the ratings franchise, broadening the moat beyond regulatory protection into data/workflow embeddedness. The 2024 acquisition of CCXI expansion and Numerated deepens vertical integration.

Moody's financial profile is elite: asset-light economics generate exceptional returns on capital, robust free cash flow, and earnings well-supported by cash. The balance sheet carries meaningful debt, but it is comfortably serviced by stable cash flows and used strategically for buybacks, not survival.

Returns on capital. ROIC consistently runs 20–30%+, far above any reasonable cost of capital (~8–10%). Reported ROE frequently exceeds 50–100% — partly an artifact of buyback-depleted equity — but even on a gross invested capital basis, returns are outstanding. MIS (ratings) operates at 55%+ margins on near-zero incremental capital; MA generates 30%+ adjusted margins with growing scale. These returns have been stable for over a decade.

Debt and leverage. Total debt is ~$7.0–7.5B against FY2025 EBITDA of roughly $3.5–3.8B, yielding net debt/EBITDA near 2x — disciplined for a business this resilient. Interest coverage exceeds 10x operating income. Maturities are well-laddered (no near-term cliff). Moody's held an investment-grade rating (Baa1/BBB+) throughout. Debt primarily funds share repurchases — aggressive, but rational given the capital-return profile. In a severe issuance downturn (2008–09 template: MIS revenue fell ~25%), the recurring MA base (~$3B+ ARR) plus residual MIS monitoring fees would comfortably cover all fixed charges.

Earnings quality. FCF/net income conversion consistently runs 90–110%. Capex is minimal (~$350–400M, mostly capitalized software). No inventory. Receivables growth has tracked revenue — no red flags. The ~$6–7B goodwill balance from acquisitions (RMS, Bureau van Dijk) warrants monitoring, though no impairments have been recorded. Auditor: KPMG LLP, no qualifications or changes. No material related-party transactions or off-balance-sheet exposures.

Runway for Reinvestment

Moody's has an exceptionally long reinvestment runway — but it is the runway of a capital-light franchise, not a capital-hungry compounder. The ratings duopoly requires almost no incremental capital to grow, producing returns on tangible capital that are effectively infinite. The constraint is the opposite of most businesses: Moody's generates far more cash than it can redeploy internally.

Management has addressed this sensibly. Organic reinvestment flows into MA product development (Decision Solutions, GenAI, KYC/compliance tools) and geographic expansion (Moody's Local in Latin America, GCR in Africa, ICR Chile). These are high-return, low-capital initiatives. The RMS acquisition (~$2B, 2019) was the largest deployment, transforming insurance analytics within MA. Remaining FCF goes primarily to buybacks and dividends.

The implied organic growth rate (retention × ROIC) is somewhat misleading here — the business grows revenue high-single-digits with minimal capital because pricing power and market expansion do the work. The real question is whether buybacks at 30-40x earnings create value. At current multiples, marginal buyback returns are mediocre (~3% earnings yield), dragging the overall capital deployment score below what the operating business deserves.

Moody's and S&P Global form a regulated duopoly controlling ~80% of global credit ratings revenue, with Fitch a distant third at ~15%. This structural dominance has been stable for decades, reinforced by the "two-rating" convention (most issuers need ratings from both MCO and SPGI), NRSRO regulatory barriers, and the near-impossibility of building a credible track record from scratch. Moody's is not meaningfully gaining or losing share in ratings — the duopoly is locked in.

The more dynamic competitive front is analytics (Moody's Analytics vs. S&P Market Intelligence, MSCI, Verisk). Here MCO has been investing aggressively — ARR grew mid-teens in FY2025 — but MA remains smaller and lower-margin than S&P's data businesses. S&P Global's IHS Markit merger gave it massive scale in data and indices that Moody's cannot match.

Moody's slight valuation premium over S&P Global reflects its faster top-line growth and AI narrative (Moody's CoPilot), but SPGI has superior diversification and a higher recurring revenue base. MSCI trades richest on its near-perfect recurring model. All three are priced for continued excellence — none is cheap on an absolute basis.

Management & Shareholder Orientation

Moody's management is well-aligned with long-term shareholders, anchored by the most powerful external governance force available: Berkshire Hathaway's ~13% stake. Buffett has held Moody's since the 2000 spin-off from Dun & Bradstreet, viewing the ratings duopoly as a toll-bridge business. That patient, owner-oriented anchor shareholder disciplines capital allocation without micromanaging.

CEO Rob Fauber, a 20-year Moody's veteran who succeeded Ray McDaniel in 2021, has continued disciplined buybacks (share count down ~30% over the past decade) and steady dividend growth. Insider ownership in percentage terms is modest — typical for an $87B market cap company — but equity-heavy compensation (performance shares tied to adjusted operating income and EPS) creates meaningful alignment. No significant pledging concerns are evident.

The board is substantively independent. The notable regulatory blemish — the $864M DOJ settlement in 2017 over pre-crisis MBS ratings — is well in the past with no material successor issues. Insiders have been routine net sellers via programmatic plans, unremarkable for a stock that has compounded at ~18% annually over a decade.

Management Competence & Ethics

Moody's management has been an outstanding capital allocator within a business that largely runs itself. The combination of aggressive buybacks, disciplined M&A, and a growing dividend has compounded shareholder value at exceptional rates.

Capital allocation is textbook. Share count has declined from ~215M (2014) to 177M (Jan 2026) — roughly 18% reduction funded by consistently strong free cash flow (~90%+ conversion of net income). The two largest acquisitions — Bureau van Dijk (~$3.5B, 2017) and RMS (~$2B, 2021) — were strategically sound, adding proprietary data assets and insurance analytics to MA's recurring revenue base. No material goodwill impairments have followed. Dividends have grown annually for 15+ consecutive years, though the yield stays sub-1% as management rightly prioritizes buybacks at high-ROIC.

Execution consistently meets or exceeds guidance. Under CEO Rob Fauber (2021–present), MA's ARR has scaled past $3.2B, the company has repeatedly raised full-year guidance mid-cycle, and adjusted operating margins have expanded. Revenue grew from ~$5.4B (2020) to over $7B (2025), hitting or beating medium-term targets set in prior investor days.

The 2008 scar is real but addressed. Moody's $864M DOJ settlement (2017) for inflated structured finance ratings during the financial crisis was a genuine ethical failure — one that predates the current leadership team. Post-crisis regulatory overhaul (Dodd-Frank, ESMA oversight) and internal governance reforms have materially reduced that specific risk. No subsequent comparable lapses have occurred. The FY2025 10-K confirms no financial restatements, no auditor disagreements, and no error corrections requiring clawback analysis. KPMG remains auditor with a clean opinion.

No material pending litigation beyond routine matters disclosed in the 10-K.

Moody's Corporation — Valuation

Moody's is a world-class compounder priced as one. At $87B market cap and 31.9x trailing earnings, the stock embeds ~13–15% annual earnings growth with a sustained quality premium — achievable but leaving thin margin of safety.

What's priced in. TTM net income is ~$2.7B (implied from P/E). To deliver a 10% annual return over five years at a 25x terminal P/E, Moody's needs to grow earnings to ~$5.6B — a 15.5% CAGR. At a more generous 28x exit multiple, the required CAGR drops to ~13%. Both scenarios assume the business executes flawlessly across MIS (cyclical debt issuance) and MA (recurring analytics), with continued buybacks shrinking the share count 2–3% annually. Achievable, but nothing can go wrong.

Reverse-engineering the forward P/E of 26.6 (FY2026E EPS ~$18.88) and projecting 13% EPS growth for five years yields ~$34.80 EPS by 2031. At 27x, that's ~$940/share or ~$150B market cap — a ~11% annual return including dividends. That's the optimistic read. The bear case — a credit cycle downturn compressing MIS revenues 20%+ for two years — could flatten EPS growth and compress multiples simultaneously.

Liquidation is irrelevant. Tangible book is negative $4.2B. The value here is entirely franchise and intangible — the duopoly moat, NRSRO designation, and data assets.

Probability-weighted expected value: ~$119B — implying ~7% annual total return from today. For a risk-free-rate-plus-equity-premium benchmark, that's below-average compensation for the capital deployed. The business is exceptional; the price reflects it.

Moody's Corporation — Long-term Valuation

Moody's is a ~2.5x compounder over 10 years, anchored by a regulatory moat with no visible expiration date, though today's 32x earnings demands near-perfect execution.

The reinvestment flywheel is asymmetric by segment. MIS (ratings) is a toll-booth franchise requiring almost zero incremental capital — every new bond issuance generates near-pure-margin revenue. MA (analytics) is where reinvestment widens the moat: acquisitions (BvD, RMS) and GenAI-enhanced workflow tools deepen switching costs inside bank risk departments. Critically, incremental capital deployed in MA has earned well — ARR has compounded mid-teens while operating margins expanded.

Compounding math: EPS grew from $7.44 (2022) to $13.67 (2025) — a 22% CAGR driven by 12% revenue growth, margin expansion to ~45%, and 1%+ annual share retirement. Normalizing to ~11-13% forward EPS growth (8-10% revenue, modest margin lift, 1.5-2% buyback yield) produces 2.8-3.4x earnings in a decade. Assuming the multiple compresses from ~32x to 25-28x and adding ~1% dividend yield, the range is roughly 2-3x over 10 years (~8-11% annualized).

What breaks the thesis: Not a recession (MIS revenue snaps back as issuance rebounds, as demonstrated in 2023-24). Watch for sustained MIS market share loss to S&P/Fitch, MA ARR growth decelerating below mid-single-digits, or regulatory action forcing fee transparency/compression in ratings. None of these are currently in motion.

Competitive relevance in 20 years: Very high probability. The NRSRO designation, issuer-pays economics, and regulatory embedding in Basel capital rules create a moat that requires legislative action to dismantle. AI is a tailwind here — Moody's builds the AI tools rather than being disrupted by them.

Moody's most durable competitive advantage — regulatory entrenchment of ratings — is also its singular existential risk. If governments dismantled the NRSRO framework or mandated a shift from the issuer-pays model, MIS's economics would face permanent impairment. This was tested post-2008: Dodd-Frank and EU CRA regulations increased oversight but ultimately reinforced the oligopoly's position. Probability of structural regulatory destruction over 10 years: below 5%.

Private credit disintermediation is real but bounded. Direct lending bypasses rated public markets, yet global public debt outstanding ($130T+) continues growing, and Moody's is reorienting MA to serve private credit workflows directly — turning a threat into a revenue opportunity.

AI commoditization of credit analysis could pressure MA margins but cannot displace the regulatory mandate that underpins MIS. Financial risk is minimal: ~$7.5B debt against ~$2.7B annual FCF (FY2025), with leverage around 2.5x EBITDA — comfortable for a business with 90%+ gross margins and counter-cyclical issuance dynamics (refinancing waves follow downturns).

Governance: the issuer-pays conflict is structural, well-known, and priced in — not a hidden risk.

Final Verdict: Moody's Corporation (MCO)

TRACK — A world-class compounder priced for perfection.

Moody's is one of the highest-quality businesses in global capital markets. The ratings duopoly is a regulatory toll bridge with near-zero incremental cost, producing 60%+ MIS margins that no competitor can replicate. The analytics franchise (MA) adds a growing recurring revenue stream now exceeding half of total revenue. Combined: $7.7B revenue, 50% operating margins, $2.6B FCF, and 77% ROE — financial metrics that belong in any business-quality hall of fame.

The problem is the price. At 32x trailing earnings and $87B market cap, the stock already impounds the next several years of double-digit EPS compounding. The base case projects ~$125B market cap by 2031 — a 7–8% annualized return. That's a positive real return, but below a 10% equity hurdle and leaves essentially no margin of safety for a business already trading near its all-time high.

Strongest argument against buying now: Every structural advantage is already visible and priced. There is no information edge in owning Moody's at 32x. The path to outsized returns requires either (a) multiple expansion from an already elevated level, or (b) revenue acceleration materially above the 10% base case — neither is the high-probability outcome.

For existing holders: HOLD. The business quality fully justifies continued ownership. Selling a compounder of this caliber to chase marginal IRR elsewhere is a mistake — compounding at 7–8% in a near-zero-risk franchise beats most alternatives on a risk-adjusted basis. But adding at current prices offers limited incremental return per dollar deployed.

For new investors: Wait for a pullback to 25–27x earnings (~$400–430), where prospective returns approach 10%+ and a genuine margin of safety exists. Moody's has traded at those levels as recently as late 2024; patience will likely be rewarded.

What would change this to BUY: A 15–20% drawdown, acceleration in private credit analytics adoption, or a structural step-up in MA margins toward 40%+.

Gaps to research further:

• Q2 2026 results and updated management guidance for MA growth trajectory
• Private credit ratings pipeline and regulatory developments (SEC/ESMA rule changes)
• AI integration impact on MA platform stickiness and pricing power